既往重度系统性红斑狼疮患者出现长期完全缓解。
Prolonged complete remission in previously severe SLE.
作者信息
Tozman E C, Urowitz M B, Gladman D D
出版信息
Ann Rheum Dis. 1982 Feb;41(1):39-40. doi: 10.1136/ard.41.1.39.
Abstract
Of 160 patients with systemic lupus erythematosus followed up in a long-term prospective study 4 with previously severe disease are in complete remission and have required no therapy for a median time of 75 months. The 4 females all presented with systemic features and a typical butterfly rash prompting early diagnosis and treatment. All patients have had complete remission of clinical and laboratory features of disease, without maintenance suppressive therapy.
摘要
在一项长期前瞻性研究中对160例系统性红斑狼疮患者进行随访，其中4例曾患有严重疾病，目前处于完全缓解状态，中位时间75个月未接受治疗。这4名女性均表现出全身症状和典型的蝶形红斑，促使早期诊断和治疗。所有患者的疾病临床和实验室特征均完全缓解，无需维持性抑制治疗。
相似文献
1
Prolonged complete remission in previously severe SLE.
Ann Rheum Dis. 1982 Feb;41(1):39-40. doi: 10.1136/ard.41.1.39.
2
Prognostic implications of active discoid lupus erythematosus and malar rash at the time of diagnosis of systemic lupus erythematosus: Results from a prospective cohort study.
Lupus. 2016 Apr;25(4):376-81. doi: 10.1177/0961203315610645. Epub 2015 Oct 8.
3
Quality of life among female patients with systemic lupus erythematosus in remission.
Rheumatol Int. 2019 Aug;39(8):1351-1358. doi: 10.1007/s00296-019-04329-1. Epub 2019 May 25.
4
Prolonged remission in systemic lupus erythematosus.
J Rheumatol. 2005 Aug;32(8):1467-72.
5
Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-naïve patients with systemic lupus erythematosus.
Rheumatology (Oxford). 2020 Nov 1;59(11):3400-3407. doi: 10.1093/rheumatology/keaa120.
6
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort.
Arthritis Care Res (Hoboken). 2024 Aug;76(8):1132-1138. doi: 10.1002/acr.25334. Epub 2024 May 2.
7
Clinical Remission and Low Disease Activity Outcomes Over 10 Years in Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken). 2019 Jun;71(6):822-828. doi: 10.1002/acr.23720. Epub 2019 May 10.
8
Clinical Features of Systemic Lupus Erythematosus in Tunisian Males.
Curr Rheumatol Rev. 2020;16(2):139-142. doi: 10.2174/1573397115666190916142945.
9
Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
Arthritis Rheum. 2006 Sep;54(9):2970-82. doi: 10.1002/art.22046.
10
Mortality in systemic lupus erythematosus: the bimodal pattern revisited.
Q J Med. 1985 Apr;55(216):87-98.
引用本文的文献
1
Treat-to-Target in Systemic Lupus Erythematosus: Reality or Pipe Dream.
J Clin Med. 2023 May 8;12(9):3348. doi: 10.3390/jcm12093348.
2
Factors associated with remission in patients with systemic lupus erythematosus: new insights into a desirable state.
Clin Rheumatol. 2018 Nov;37(11):3033-3042. doi: 10.1007/s10067-018-4226-8. Epub 2018 Jul 28.
3
Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.
Lupus Sci Med. 2017 Feb 8;4(1):e000192. doi: 10.1136/lupus-2016-000192. eCollection 2017.
4
Treat to target in systemic lupus erythematosus: a commentary.
Clin Rheumatol. 2016 Aug;35(8):1903-1907. doi: 10.1007/s10067-016-3346-2. Epub 2016 Jul 12.
5
Inactive disease and remission in childhood-onset systemic lupus erythematosus.
Arthritis Care Res (Hoboken). 2012 May;64(5):683-93. doi: 10.1002/acr.21612.
6
Lupus nephritis in childhood and adolescence.
Pediatr Nephrol. 1994 Apr;8(2):230-49. doi: 10.1007/BF00865490.
7
The treatment of lupus nephritis.
Pediatr Nephrol. 1989 Jul;3(3):350-62. doi: 10.1007/BF00858546.
本文引用的文献
1
OBSERVATIONS ON THE NATURAL COURSE OF DISSEMINATED LUPUS ERYTHEMATOSUS.
Medicine (Baltimore). 1964 May;43:387-91. doi: 10.1097/00005792-196405000-00016.
2
Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis.
J Lab Clin Med. 1961 Apr;57:495-511.
3
Systemic lupus erythematosus: recent advances in its diagnosis and treatment.
Ann Intern Med. 1956 Aug;45(2):163-84. doi: 10.7326/0003-4819-45-2-163.
4
Late mortality in SLE--"the price we pay for control".
J Rheumatol. 1980 May-Jun;7(3):412-6.
5
Late-stage lupus nephropathy.
J Rheumatol. 1974 Jun;1(2):166-75.
6
Steroid-induced morbidity mimicking active systemic lupus erythematosus.
Ann Intern Med. 1973 Apr;78(4):558-60. doi: 10.7326/0003-4819-78-4-558.
7
The bimodal mortality pattern of systemic lupus erythematosus.
Am J Med. 1976 Feb;60(2):221-5. doi: 10.1016/0002-9343(76)90431-9.
8
Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis.
Am J Med. 1975 May;58(5):644-54. doi: 10.1016/0002-9343(75)90500-8.
9
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features.
Am J Med. 1979 Feb;66(2):210-5. doi: 10.1016/0002-9343(79)90529-1.
Zotero 插件